Arcus Biosciences (RCUS) Capital Expenditures Growth (1y) (2018 - 2025)
Arcus Biosciences (RCUS) Capital Expenditures Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -27.93% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arcus Biosciences | 3.73 Bn | 2.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 116.67% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -150.00% |
| Sep 30, 2024 | -600.00% |
| Mar 31, 2024 | -87.50% |
| Dec 31, 2023 | 500.00% |
| Sep 30, 2023 | 33.33% |
| Mar 31, 2023 | 166.67% |
| Dec 31, 2022 | 224.61% |
| Sep 30, 2022 | -40.90% |
| Jun 30, 2022 | 38.56% |
| Mar 31, 2022 | 7.76% |
| Dec 31, 2021 | -198.65% |
| Sep 30, 2021 | 310.02% |
| Jun 30, 2021 | -4,298.65% |
| Mar 31, 2021 | 1,232.06% |
| Dec 31, 2020 | 730.10% |
| Sep 30, 2020 | 125.09% |
| Jun 30, 2020 | -109.26% |
| Mar 31, 2020 | -45.00% |